Website: BenevolentAI
Business Area(s):
Description:
Benevolent AI is developing artificial intellegence for scientific innovation.
In response to the global coronavirus pandemic, BenevolentAI announced that baricitinib is entering clinical testing as a potential treatment for COVID-19. BenevolentAI identified the drug in recent research by using artificial intelligence and machine learning. The trial by Eli Lilly will investigate the drug’s efficacy and safety.
Career Page(s):
Internship Page(s):
Location(s):
London
United Kingdom
See map: Google Maps
Cambridge
United Kingdom
See map: Google Maps
New York
NY
United States
See map: Google Maps